August 29, 2017 / 9:13 AM / a month ago

BRIEF-Alzinova Q2 pre-tax loss narrows to SEK 548,102

Aug 29 (Reuters) - ALZINOVA AB:

* Q2 PRE-TAX LOSS SEK 548,102 VERSUS LOSS SEK 689,575 YEAR AGO

* Q2 NET SALES SEK 0 VERSUS SEK 0 YEAR AGO

* CONTINUES TO FOCUS PRIMARILY ON THE DEVELOPMENT OF THE VACCINE PRODUCT, ALZ-101 - GOAL IS TO OBTAIN APPROVAL TO INITIATE CLINICAL STUDIES 2018

* SAYS IS CURRENTLY EVALUATING THE POSSIBILITIES OF RESUMING THE DEVELOPMENT OF THE ANTIBODY ALZ-201

Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below